Mabqi’s pipeline leverages our Ab discovery experience of more than 20 successful programs. Our proprietary therapeutic antibodies gather outstanding properties such as pH sensitivity, enhanced developability capabilities and high clinical interest.
Partnering & collaboration
Focused on oncology area, our innovative lead candidate’s portfolios are fully open to partnering or out-licensing opportunities. We believe that combining the finest technologies and ideas will push the limits of current drug development to provide safer and more effective immunotherapy treatments.
Mabqi is on open to partnership discussion on original targets and mechanism of actions that would benefit from our outstanding technology